News

FDA approves first at-home HPV test for cervical cancer: How it works
Great news for women's health. The FDA has approved Teal Wand, the first at-home cervical cancer screening test. This test ...
North Country Public Radio2h
The FDA approves first U.S. at-home tool as a Pap-smear alternative
Women can use a wand to collect a vaginal sample, then mail it to a lab that will screen for cervical cancer. The device will ...
First at-home HPV test approved by FDA, could replace Pap smear
The first at-home cervical cancer screening test has been approved by the Food and Drug Administration, according to the product's manufacturer. It may offer an alternative to traditional in-person ...
FDA approves at-home pap smear alternative device for cervical cancer screening
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home ...
FDA approves at-home cervical cancer screening test
A diver on an expedition off the coast of Cabo San Lucas, Mexico, captured stunning footage showing the moment another swam ...
US approves first at-home cervical cancer screening device
The US Food and Drug Administration has approved an at-home cervical cancer screening tool as an alternative to Pap smears by ...
First at-home test kit for cervical cancer approved by the FDA, company says
WASHINGTON (AP) — U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own ...
PBS14d
Conquering Cervical Cancer
A definitive documentary with a soaring ambition: to help accelerate the elimination of cervical cancer for every woman and girl in the USA and beyond. Conquering Cervical Cancer is available to ...
Seeking Alpha15d
Summit plunges 35%; partner Akesso wins FDA nod for cancer drug
Shares of Summit Therapeutics (NASDAQ:SMMT) ended five straight sessions of gains on Friday as the stock lost ~35%, triggering a trading halt, a day after the FDA approved its partner Akeso’s ...
FiercePharma15d
Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in head and neck cancer subtype
Previously, the drug has been approved in China for nasopharyngeal carcinoma, a rare cancer that develops in the nasopharynx, the upper part of the throat at the back of the nose. A separate ...
WebMD15d
FDA OKs New Drug for Rare Head and Neck Cancer
April 25, 2025 — The FDA has approved a new drug for adults with a rare type of head and neck cancer known as non-keratinizing nasopharyngeal carcinoma (NPC) after studies showed that ...
Medscape15d
FDA Approves Penpulimab for Nasopharyngeal Cancer
The US Food and Drug Administration (FDA ... Study results will be presented at the 2025 American Association for Cancer Research Annual Meeting, Akeso noted in the press release.